AbbVie to invest $380 million to build two API facilities in Illinois

AbbVie announced a $380 million investment to build two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus, expanding domestic production for neuroscience and obesity medicines.

“AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus.”reuters.com

• 1 source
• reuters.comAbbVie to invest $380 million to expand US manufacturing in Illinois | ReutersFeb 23, 2026

Summarized from public sources; check the original articles before acting on it.